Skip to main content

Table 2 Expression levels of miR-206 and CCND2 in fine-needle aspiration cytology of patients with thyroid carcinoma and benign thyroid nodules

From: CCND2 and miR-206 as potential biomarkers in the clinical diagnosis of thyroid carcinoma by fine-needle aspiration cytology

Group

n

miR-206

CCND2

Patients with benign thyroid nodules

65

4.15 ± 1.63

1.12 ± 0.59

Patients with thyroid carcinoma

65

1.38 ± 0.93

2.52 ± 0.93

t value

-

19.060

41.197

P value

-

0.000

0.000

  1. t value was calculated by t-test